Susan Jackson

ORCID: 0000-0003-0152-3033
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Telomeres, Telomerase, and Senescence
  • DNA Repair Mechanisms
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • PARP inhibition in cancer therapy
  • Ovarian cancer diagnosis and treatment
  • Immunodeficiency and Autoimmune Disorders
  • Clostridium difficile and Clostridium perfringens research
  • Gastrointestinal Tumor Research and Treatment
  • Mass Spectrometry Techniques and Applications
  • Bacillus and Francisella bacterial research
  • Bacteriophages and microbial interactions
  • Probiotics and Fermented Foods
  • HIV Research and Treatment
  • Hemoglobin structure and function
  • Immunotherapy and Immune Responses
  • Tuberculosis Research and Epidemiology
  • Long-Term Effects of COVID-19
  • interferon and immune responses
  • Immune responses and vaccinations
  • Diabetes and associated disorders
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Macrophage Migration Inhibitory Factor
  • PI3K/AKT/mTOR signaling in cancer

Cedars-Sinai Medical Center
2025

University of Oxford
2020-2024

Jenner Institute
2020-2024

Southampton General Hospital
2023

Middlemore Hospital
2021-2022

The University of Melbourne
2020

Austin Health
2020

Peninsula Health
2020

Eastern Health
2020

Monash Health
2020

Merryn Voysey Sue Ann Costa Clemens Shabir A. Madhi Lily Yin Weckx Pedro M. Folegatti and 95 more Parvinder K. Aley Brian Angus Vicky L. Baillie Shaun Barnabas Qasim Bhorat Sagida Bibi Carmen Briner Paola Cicconi Andrea M. Collins Rachel Colin-Jones Clare Cutland Thomas C. Darton Keertan Dheda C.J. Duncan Katherine R. W. Emary Katie Ewer Lee Fairlie Saul N. Faust Shuo Feng Daniela M. Ferreira Adam Finn Anna L. Goodman Catherine Green Christopher Green Paul T. Heath Catherine Hill Helen Hill Ian Hirsch Susanne H. Hodgson Alane Izu Susan Jackson Daniel Jenkin Carina C. D. Joe Simon Kerridge Anthonet Koen Gaurav Kwatra Rajeka Lazarus Alison M. Lawrie Alice Lelliott Vincenzo Libri Patrick Lillie Raburn M. Mallory Ana Verena Almeida Mendes Eveline Pı́polo Milan Angela M. Minassian Alastair McGregor Hazel Morrison Yama F Mujadidi Anusha Nana Peter O’Reilly Sherman D. Padayachee Ana Maria Pittella Emma Plested Katrina M. Pollock Maheshi Ramasamy Sarah Rhead Alexandre Vargas Schwarzbold Nisha Singh Darren Smith Rinn Song Matthew D. Snape Eduardo Sprinz Rebecca Sutherland Richard Tarrant Emma C. Thomson M. Estée Török Mark Toshner David P. J. Turner Johan Vekemans Tonya Villafana Marion Watson Christopher J. Williams Alexander D. Douglas Adrian V. S. Hill Teresa Lambe Sarah C. Gilbert Andrew J. Pollard Marites Aban Fatola Abayomi Kushala W.M. Abeyskera Jeremy Aboagye Matthew Adam Kirsty Adams James P. Adamson Yemi Adelaja Gbadebo Adewetan Syed Adlou Khatija Ahmed Yasmeen Akhalwaya Saajida Akhalwaya Andrew Alcock Aabidah Ali Elizabeth Allen Lauren Allen Thamires C. D. S. C Almeida

SummaryBackgroundA safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of COVID-19 pandemic. We evaluated safety efficacy ChAdOx1 nCoV-19 in a pooled interim analysis four trials.MethodsThis includes data from ongoing blinded, randomised, controlled trials done across UK, Brazil, South Africa. Participants aged 18 years older were randomly assigned (1:1) or (meningococcal group A,...

10.1016/s0140-6736(20)32661-1 article EN cc-by The Lancet 2020-12-08
Katie Ewer Jordan R. Barrett Sandra Belij‐Rammerstorfer Hannah Sharpe Rebecca Makinson and 95 more Richard Morter Amy Flaxman Daniel Wright Duncan Bellamy Mustapha Bittaye Christina Dold Nicholas M. Provine Jeremy Aboagye Jamie Fowler Sarah E. Silk Jennifer Alderson Parvinder K. Aley Brian Angus Eleanor Berrie Sagida Bibi Paola Cicconi Elizabeth Clutterbuck Irina Chelysheva Pedro M. Folegatti Michelle Fuskova Catherine Green Daniel Jenkin Simon Kerridge Alison M. Lawrie Angela M. Minassian Maria Moore Yama F Mujadidi Emma Plested Ian Poulton Maheshi Ramasamy Hannah Robinson Rinn Song Matthew D. Snape Richard Tarrant Merryn Voysey Marion Watson Alexander D. Douglas Adrian V. S. Hill Sarah C. Gilbert Andrew J. Pollard Teresa Lambe Aabidah Ali Elizabeth Allen Megan Baker Eleanor Barnes Nicola Borthwick Amy Boyd Charlie Brown-O’Sullivan Joshua Burgoyne Nicholas Byard Ingrid Cabrera Puig Federica Cappuccini Jee-Sun Cho Paola Cicconi Elizabeth Clark Wendy E.M. Crocker Mehreen S. Datoo H. Dele Davies Francesca R. Donnellan Susanna Dunachie Nick J. Edwards Sean C. Elias Julie Furze Ciarán Gilbride Giacomo Gorini Gaurav Gupta Stephanie A. Harris Susanne H. Hodgson Mimi M. Hou Susan Jackson Kathryn Jones Reshma Kailath Lloyd D. W. King Colin W. Larkworthy Yuanyuan Li Amelia M. Lias Aline Linder Samuel Lipworth Raquel Lopez Ramon Meera Madhavan Emma Marlow Julia L. Marshall Alexander J. Mentzer Hazel Morrison Nathifa Moya Ekta Mukhopadhyay Andrés Noé Fay L. Nugent Dimitra Pipini David Pulido-Gomez Fernando Ramos Lopez Adam Ritchie Indra Rudiansyah Stephannie Salvador Helen Sanders

10.1038/s41591-020-01194-5 article EN Nature Medicine 2020-12-17

During investigation of a gastroenteritis outbreak in chronic care institution, Norwalk virus was found stool specimens from two individuals and bacterial isolates presumptively identified as Bacillus cereus were isolated four (including one with virus) spice. Phage typing confirmed all clinical phage type 2. All subsequently B. thuringiensis when tested result related study (L. Leroux, personal communication). Eight 10 spice 4. showed cytotoxic effects characteristic enterotoxin-producing...

10.1111/j.1472-765x.1995.tb01017.x article EN Letters in Applied Microbiology 1995-08-01

A safety and immunogenicity trial was conducted in vaccinia-immune vaccinia-naive human immunodeficiency virus (HIV)-uninfected adults who were randomized to receive 10(6) or 10(7) TCID50 of canarypox (ALVAC) vector expressing HIV-1MN gp160 10(5.5) ALVAC-rabies glycoprotein control at 0 1 2 months ALVAC-gp160 50 microg HIV-1SF2 recombinant (r) gp120 microfluidized emulsion 9 12 months; others received rgp120 0, 1, 6, months. All vaccines well-tolerated. Neither status before vaccination nor...

10.1086/515288 article EN The Journal of Infectious Diseases 1998-05-01

Abstract An NAD-specific glutamate dehydrogenase has been isolated from Blastocladiella emersonii, purified over 100-fold, and some of its kinetic parameters studied. Saturation curves with NAD+ as variable substrate were largely sigmoidal at high concentrations. plots for hyperbolic except low levels when activated the reaction. Double reciprocal velocity nonlinear. The intense activation by described a biphasic character in diagnostic plots. On other hand, substrates, NADH α-ketoglutarate,...

10.1016/s0021-9258(18)93329-6 article EN cc-by Journal of Biological Chemistry 1968-06-01

Abstract The substrates, NAD+, NADH, and to a lesser extent, glutamate, of freely reversible glutamic dehydrogenase from Blastocladiella emersonii, diverse allosteric modulators (AMP, ADP, Ca++, Mn++) have been shown bind the enzyme prevent it dissociating into monomers at alkaline pH, high ionic strength, under hydrodynamic shear. At fixed pH these ligands display varying magnitude effectiveness as follows: NADH) g Mn++ glutamate. dissociates irreversibly an active tetramer (mol wt 200,000...

10.1016/s0021-9258(18)63666-x article EN cc-by Journal of Biological Chemistry 1969-10-01

A nicotinamide adenine dinucleotide-specific isocitric dehydrogenase has been isolated and purified 450-fold from Blastocladiella emersonii. The enzyme a monomeric molecular weight of 110,000 ± 10,000. It is capable aggregating to polymers ranging 200,000 500,000 higher at acid pH levels. At alkaline values, it exists as monomer. aggregated inactive the monomer active. Under influence various ligands (citrate, isocitrate, Mn++, Mg++), can be converted difference 1 unit (6.5 7.5) changes...

10.1016/s0021-9258(19)78247-7 article EN cc-by Journal of Biological Chemistry 1969-05-01

Bacillus cereus is responsible for an increasing number of food poisoning cases. By using 12 bacteriophages isolated from sewage, a typing scheme B. isolates outbreaks or sporadic cases was developed. The phages belonged to three morphotypes. Ten with contractile tails and icosahedral heads were members the Myoviridae family, two noncontractile Siphoviridae family. Phage 11 represented new species. It had isometric head very long tail wavy fibers one largest viruses known. vast majority 166...

10.1128/jcm.33.3.636-640.1995 article EN Journal of Clinical Microbiology 1995-03-01

A series of Clostridium perfringens-related gastrointestinal outbreaks occurred over a period several months among elderly, chronic care patients in psychiatric hospital. Several serotypes C. perfringens and many nontypeable isolates were found. The distribution certain the incidence detection enterotoxin fecal extracts related to wards on which resident (six involved). reported have or recurring incontinence diarrhea both. With background elevated spore counts diarrhea, only could provide...

10.1128/jcm.23.4.748-751.1986 article EN Journal of Clinical Microbiology 1986-04-01

D.E. MAHONY, R. AHMED AND S.G. JACKSON, 1992. Twenty‐one stool specimens obtained from persons implicated in two food poisoning outbreaks at the same institution Smith Falls, Ontario, were examined for Clostridium perfringens. Ninety‐two colonies of Cl. perfringens (3–5 per specimen) typed with antisera, bacteriocins and by plasmid analysis. They also tested vitro production bacteriocin enterotoxin. Sixteen 21 directly This was detected 13, five which individuals listed as ‘asymptomatic’...

10.1111/j.1365-2672.1992.tb01840.x article EN Journal of Applied Bacteriology 1992-04-01

Culture supernatants of 30 enterotoxin-producing Bacillus cereus isolates produced a characteristic progressive destruction McCoy cell monolayers. Enterotoxin-negative B. and other group 1 spp. caused no monolayer disruption. The tissue culture system appears to provide rapid screening assay for detection cereus.

10.1128/jcm.31.4.972-974.1993 article EN Journal of Clinical Microbiology 1993-04-01

The 1% or Less Campaign is an effective research-tested program for reducing saturated fat intake by encouraging individuals to switch low-fat milk. All published studies have been conducted in small communities with mostly White populations. 6-week intervention included a media campaign, public relations, and taste tests. effectiveness was measured using sales data cross-sectional telephone surveys. Survey results showed significant increase milk consumption from 30.2% 40.8% of drinkers ( p...

10.1177/1090198106290621 article EN Health Education & Behavior 2006-12-16

A 30-min fluorogenic test was developed for differentiation of members the Candida parapsilosis group from other species commonly encountered in clinical material. The substrate, 4-methylumbelliferyl-beta-D-glucoside, utilized to assay beta-glucosidase activity. total 50 C. isolates and 135 four were tested. Assay sensitivity specificity 100 99.3%, respectively. procedure adapted use with a spectrofluorometer.

10.1128/jcm.27.1.203-206.1989 article EN Journal of Clinical Microbiology 1989-01-01

The diagnostic application of an enzyme immunoassay for Clostridium perfringens type A enterotoxin was evaluated. Test results from 100 individuals associated with C. gastroenteritis outbreaks and 111 control were included. assay sensitivity 93.7%, the specificity 98.7%.

10.1128/aem.52.4.969-970.1986 article EN Applied and Environmental Microbiology 1986-10-01

Aims The influence of human factors on safety in healthcare settings is well established, with targeted interventions reducing risk and enhancing team performance. In experimental early phase clinical research participant paramount safeguarded by guidelines, protocolized care staff training; however, the real‐world interaction implementation these risk‐mitigating measures has never been subjected to formal system‐based assessment. Methods Independent structured observations, systematic...

10.1111/bcp.15949 article EN cc-by-nc British Journal of Clinical Pharmacology 2023-10-31
Coming Soon ...